Cargando…

The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis

Recent studies have shown that deubiquitination plays a key role in tumor progression, metastasis, resistance to chemotherapy drugs, and prognosis. In this study, we investigated the effects of the deubiquitinating enzyme USP22 on the expression of the drug-resistance genes BMI1 and EZH2 in hepatoce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Run, Tang, Fang, Gong, Jianhua, Zhang, Jing, Lei, Biao, Li, Bo, Wei, Yangchao, Liang, Xingsi, Tang, Bo, He, Songqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125798/ https://www.ncbi.nlm.nih.gov/pubmed/27920552 http://dx.doi.org/10.2147/OTT.S110985

Ejemplares similares

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2023)

JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells
por: Tang, Bo, et al.
Publicado: (2015)

Correction: JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells
por: Tang, Bo, et al.
Publicado: (2020)

The mechanism underlying alpinetin-mediated alleviation of pancreatitis-associated lung injury through upregulating aquaporin-1
por: Liang, Xingsi, et al.
Publicado: (2016)

HOXA7 plays a critical role in metastasis of liver cancer associated with activation of Snail
por: Tang, Bo, et al.
Publicado: (2016)

Retraction Note: HOXA7 plays a critical role in metastasis of liver cancer associated with activation of Snail
por: Tang, Bo, et al.
Publicado: (2023)

MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2
por: Zhang, Yi, et al.
Publicado: (2015)

MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression
por: Tang, Bo, et al.
Publicado: (2016)

Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-catenin signaling
por: Tang, Bo, et al.
Publicado: (2016)

Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression
por: Zhang, Yi, et al.
Publicado: (2019)

The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma
por: Wu, Shi-yi, et al.
Publicado: (2022)

USP21 promotes cell proliferation and metastasis through suppressing EZH2 ubiquitination in bladder carcinoma
por: Chen, Yong, et al.
Publicado: (2017)

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer
por: Pietersen, Alexandra M, et al.
Publicado: (2008)

USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt
por: Zhang, Jing, et al.
Publicado: (2017)

Targeting EZH2 for Cancer Therapy: Progress and Perspective
por: Li, Chi Han, et al.
Publicado: (2015)

microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway
por: Zhang, Yi, et al.
Publicado: (2018)

The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells
por: Wang, Yu, et al.
Publicado: (2020)

USP7 deubiquitinates and stabilizes EZH2 in prostate cancer cells
por: Lee, Jae Eun, et al.
Publicado: (2020)

Upregulation of Akt/NF-κB-regulated inflammation and Akt/Bad-related apoptosis signaling pathway involved in hepatic carcinoma process: suppression by carnosic acid nanoparticle
por: Tang, Bo, et al.
Publicado: (2016)

USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma
por: Ning, Zhen, et al.
Publicado: (2022)

USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma
por: Zeng, Kai, et al.
Publicado: (2023)

Cloning and Characterization of the Human USP22 Gene Promoter
por: Xiong, Jianjun, et al.
Publicado: (2012)

USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein
por: Ma, Yue, et al.
Publicado: (2017)

Derepressing of STAT3 and USP7 contributes to resistance of DLBCL to EZH2 inhibition
por: He, Chenyun, et al.
Publicado: (2023)

Clinical Significance of Ubiquitin Specific Protease 7 (USP7) in Predicting Prognosis of Hepatocellular Carcinoma and its Functional Mechanisms
por: Wang, Xujing, et al.
Publicado: (2018)

circUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated With Poor Prognosis
por: Yu, Jinling, et al.
Publicado: (2020)

Overexpression of Yes‐associated protein and its association with clinicopathological features of hepatocellular carcinoma: A meta‐analysis
por: Lin, Chengjie, et al.
Publicado: (2017)

USP22 promotes IRF3 nuclear translocation and antiviral responses by deubiquitinating the importin protein KPNA2
por: Cai, Zeng, et al.
Publicado: (2020)

USP44 Promotes the Tumorigenesis of Prostate Cancer Cells through EZH2 Protein Stabilization
por: Park, Jae Min, et al.
Publicado: (2019)

The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
por: Steele, J C, et al.
Publicado: (2006)

High expression of USP22 predicts poor prognosis and advanced clinicopathological features in solid tumors: a meta-analysis
por: Yang, Xiaohui, et al.
Publicado: (2018)

Aberrant Upregulation of 14-3-3σ and EZH2 Expression Serves as an Inferior Prognostic Biomarker for Hepatocellular Carcinoma
por: Zhang, Yi, et al.
Publicado: (2014)

Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of Resistance
por: Chang, Yung-Sheng, et al.
Publicado: (2022)

Targeting Glioma Stem Cells through Combined BMI1 and EZH2 Inhibition
por: Jin, Xun, et al.
Publicado: (2017)

Deubiquitination in prostate cancer progression: role of USP22
por: Nag, Nivedita, et al.
Publicado: (2020)

EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
por: Chen, Shaofei, et al.
Publicado: (2018)

USP21 promotes cell proliferation by maintaining the EZH2 level in diffuse large B‐cell lymphoma
por: Ma, Huixian, et al.
Publicado: (2021)

Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
por: Schümann, Franziska Lea, et al.
Publicado: (2021)

USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway
por: Ling, Sunbin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5a83h396snildfesnuar31l3nd